Imperial Oil Limited Common Stock vs MiniMed Group Inc. Common Stock — how do they compare? Imperial Oil Limited Common Stock trades at $129.6 (market cap $62.22B), while MiniMed Group Inc. Common Stock trades at $16.74 (market cap $5.18B). The key difference: Imperial Oil Limited Common Stock is far larger — about 12× MiniMed Group Inc. Common Stock's market cap, and Imperial Oil Limited Common Stock pays a 1.9% dividend while MiniMed Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IMO | MMED | |
|---|---|---|
Market Cap | $62.22B | $5.18B |
Volume | 560,544 | 33,606,669 |
Sector | Energy | Health |
52-Week High | $138.33 | $23.84 |
52-Week Low | $83.72 | $10.80 |
Enterprise Value | $63.13B | $4.98B |
Dividend Yield | 1.9% | — |
Typical Hold Time | — | 6 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MMED trades at $18.40, down 2.13% today, with technical indicators showing bearish momentum. The company reported revenue growth to $2.72B in 2025 but posted a net loss of -$250M. Recent news highlights Medtronic's exchange offer completion and MiniMed's new product launches. Analyst consensus remains strongly bullish with 100% buy ratings and a $25.73 price target, representing 40% upside potential from current levels.
Despite negative profitability metrics and bearish technical signals, MMED maintains strong analyst support and revenue growth trajectory. Key risks include persistent net losses, high short interest, and execution challenges in the competitive diabetes technology market. The stock offers potential upside if new product cycles drive margin improvement and profitability.
Trailing returns across standard periods
Latest headlines on both assets
Imperial Oil Limited is a Canadian integrated energy company that explores for and produces crude oil and natural gas, operates oil sands projects at Cold Lake, Kearl, and Syncrude, and refines and markets petroleum products under the Esso and Mobil brands. ExxonMobil Corporation holds a majority ownership stake in the company.
Read more on IMO →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →